Zoom's $51M Bet That Became $1.27 Billion: Why the Anthropic Stake Is Rewriting the ZM Story

By Balaji N, CFP · True Value Research · June 16, 2026

The Hidden Gem That Wasn't Hidden Enough

In May 2023, Zoom Video Communications made a quiet investment through its venture arm. The amount — approximately $51 million — was modest by Silicon Valley standards, tied to a product partnership to bring Anthropic's Claude models into Zoom's collaboration suite. The investment was disclosed in filings but attracted little attention. Zoom was still in the middle of a painful post-pandemic derating, and the Street was focused on seat count churn and net expansion rates, not a venture bet in an unproven AI startup.

Three years later, that $51 million is worth $1.27 billion.

Anthropic has confidentially filed for an IPO following a $65 billion fundraising round that valued the company at a reported $965 billion — surpassing OpenAI as the most valuable AI startup in the world. As the filing became public in late May 2026, Zoom shares surged nearly 11% in a single session to $114.56, as investors scrambled to reprice an asset that had been sitting invisibly on the balance sheet. Zoom, once a pandemic darling turned growth laggard, is suddenly being looked at again — not for video conferencing metrics, but for what it owns.

How the Investment Grew

Zoom's Anthropic relationship began as a product deal. The $51 million initial investment in 2023 gave Zoom preferred shares in Anthropic and a commercial agreement to integrate Claude's capabilities into Zoom AI features — meeting summaries, transcription, intelligent assistants, and the AI Companion product the company has been building since. It was a sensible bet: Zoom needed credible AI capabilities to defend its core product against Microsoft Teams and Google Meet, and buying access to frontier-model intelligence via a vendor deal was faster than building in-house.

What Zoom got additionally — and what most investors missed — was equity participation in one of the fastest-growing private AI companies in history. In Q1 2026, Zoom made an additional $46 million investment in Anthropic preferred stock, bringing total invested capital to approximately $97 million and the carrying value to $1.2669 billion, based on Anthropic's February 2026 financing round at a $380 billion post-money valuation. At Anthropic's current reported pre-IPO valuation of $965 billion, analysts put the value of Zoom's stake in the $2–$4 billion range.

Why the Market Is Repricing ZM

For most of the past three years, Zoom's equity story has been defined by what it lost: the pandemic-era growth premium, the market's enthusiasm for video conferencing as a secular trend, and ultimately the narrative of being a standalone productivity platform rather than a feature within Microsoft 365. The stock declined from its 2020 peak of $559 to a trough around $60.

The Anthropic stake changes the framing concretely. Zoom has a market capitalisation of approximately $35 billion. If the Anthropic stake is worth $2–4 billion — increasingly the base case as IPO paperwork moves the asset toward liquidity — then investors are paying roughly $31–33 billion for everything else Zoom owns: a video conferencing platform with 220+ million daily meeting participants, an AI Companion product with growing enterprise adoption, a phone system, a contact centre business, and a balance sheet with over $7 billion in cash and investments.

Put differently: the market may be materially undervaluing the core business once the Anthropic asset is properly attributed. This is the argument that has drawn renewed attention to ZM from value-oriented funds.

ZoomMate and the Enterprise AI Play

The Anthropic stake would be less interesting if Zoom's core business were in freefall. It is not. The company's enterprise business has stabilised, and its AI Companion — powered by Claude — has become a credible differentiation story against Microsoft Teams. The product integrates meeting summaries, action item extraction, real-time coaching, and agentic workflows that automate follow-up tasks into enterprise systems.

The company is now positioning ZoomMate — its AI-powered meeting assistant — as a workflow automation layer that sits on top of video conferencing. Zoom has a unique dataset advantage: it processes hundreds of millions of meeting hours, contains rich professional relationship graphs, and captures decision-making context that no email or document system can match. If ZoomMate can turn that data into actionable enterprise workflows, Zoom's addressable market expands significantly beyond video seats.

This creates a virtuous loop: Zoom is both a financial holder of Anthropic equity and an enterprise distribution partner for Claude. As Anthropic's model capabilities improve, Zoom's AI product improves alongside it — while the financial stake grows in value.

The IPO Catalyst: What Happens Next

Anthropic's confidential IPO filing is the event that crystallised the stake's value in the market. A confidential filing means the company has submitted its S-1 to the SEC but has not yet made it public — standard for large IPOs that allows the company to address SEC comments before the public roadshow. Market participants are interpreting the filing as a signal that the IPO is likely to proceed within 12–18 months, subject to market conditions.

For Zoom, IPO completion would have several concrete effects. First, it creates a liquid market price for the stake, removing the discount that private-market holdings typically carry. Second, it would likely trigger a mark-up of the carrying value if the IPO prices above the current implied valuation. Third, it gives Zoom the option to sell some or all of the stake post-lockup and return capital to shareholders — either via buybacks or a special dividend.

Analysts at Baird estimate the Anthropic stake could be worth $2–$4 billion at IPO versus the current $1.27 billion carrying value. That reflects uncertainty about dilution from subsequent rounds — but even at the low end it represents a meaningful addition to Zoom's intrinsic value per share.

Risks

Private company valuations can compress between filing and IPO, particularly if market conditions deteriorate or appetite for high-multiple AI names cools. Zoom's stake will be subject to a post-IPO lockup (typically 180 days) during which it cannot sell regardless of the market price. There is also concentration risk: $1.27 billion in a single private equity position is not conservative asset allocation.

And the core video conferencing business still faces structural headwinds. Microsoft Teams and Google Meet are deeply embedded in enterprise IT stacks. Zoom's growth rates are a fraction of what they were in 2020–2021, and the company must demonstrate that its AI Companion and ZoomMate strategy can reaccelerate net revenue retention before the market fully re-rates the stock.

The Investment Case

Zoom is a genuinely interesting situation at $114. The core business — a profitable, cash-generative enterprise software company with $7 billion in cash — is reasonably valued on its own. The Anthropic stake adds a potentially transformative asset moving toward liquidity. And the AI Companion strategy offers a credible path to reigniting enterprise growth.

The risk is that the market has already priced a significant portion of the Anthropic optionality in the recent 11% move. The opportunity is for investors who believe Anthropic will IPO at or above current implied valuations, and that the core business is more resilient than the past three years of share price performance suggests.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice or a solicitation to buy or sell any securities. Always consult a qualified financial advisor before making investment decisions.